Navigation Links
New microscope peers into secret lives of cells
Date:11/21/2007

See those white sparks? asks Kirk Czymmek, as he points to the video on his computer screen of a highly magnified heart cell in action. Tiny fireworks flash across the screen with every pulsation of the cell.

That's calcium, Czymmek notes. Scientists have discovered that there is a large release of calcium with every heartbeat. If we don't see those sparks, he notes, you have a major problem--perhaps even heart failure.

Czymmek has a bird's-eye view into the fascinating and rarely seen world of the microscopic, as director of the University of Delaware's Bio-imaging Center.

The center, a component of UD's Delaware Biotechnology Institute, is equipped with the latest technology for microscopic explorations into a diversity of intriguing subjects under investigation by University researchers, from plants that can decontaminate soils of toxic metal pollutants, to carbon nano-bombs for destroying cancer cells.

Czymmek, who also is an associate professor of biological sciences at UD, recently showcased the latest addition to the University's suite of high-tech imaging tools--a state-of-the-art laser-scanning confocal microscope. UD is among a handful of universities that own one of the million-dollar instruments.

The device, known as the LSM 510 DUO, manufactured by Carl Zeiss MicroImaging Inc., typically uses a laser beam to observe a single focal point at a time on its subject--acquiring over a quarter-million picture elements, or pixels, in a single scan, which takes about one second. However, if the laser beam is shaped into a line and swept across the sample, it can scan an image over 100 times faster.

The microscope is particularly useful in examining thick samples such as muscle tissue at high resolution, Czymmek says, because a series of scans may be made at different depths within the sample and assembled automatically in minutes, yielding breathtakingly detailed, three-dimensional images, much like an
'/>"/>

Contact: Tracey Bryant
tbryant@udel.edu
302-831-8185
University of Delaware  
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. From Microscope to Stethoscope: the MUHCs distinguished public lecture series begins a second seaso
2. From microscope to stethoscope: The MUHCs public lecture series begins its 2nd season tomorrow
3. HR Under the Microscope: Metrics to Drive Costs Down Across HR Functions
4. Study Author Urges Peers to Stop Using Pain Pumps in the Shoulder Joint as Seasonal Surge in Use Approaches
5. Scientists Probe Sepsis Deadly Secrets
6. Black America Urged to Confront Its Secret Pain: Depression
7. Scientists explain how insulin secreting cells maintain their glucose sensitivity
8. PA Secretary of Public Welfare Responds to Warren State Hospital Closure Rumors
9. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
10. HHS Secretary Leavitt to Address Columbia School of International and Public Affairs
11. Former HHS Secretary Dr. Louis Sullivan, Lt. Gov. Cagle Address Need to Improve Quality of Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New microscope peers into secret lives of cells
New microscope peers into secret lives of cells
(Date:8/28/2008)... versus Q2 2007 - Nine new Centers opened to da...ll/ - CRH Medical Corporation,(CRM:TSX-V) announce...nths,ended June 30, 2008 (all figures are in US do..., 2008 increased 138% to $1,653,891 compared to,$6...e six months ended June,30, 2008 increased 150% to...
(Date:8/28/2008)...PRNewswire-FirstCall/ -- ISTA Pharmaceuticals,Inc...t at the Thomas Weisel,Partners Healthcare Confere...ber 4, 2008 at the Four Seasons Hotel in Boston, M... Vicente Anido, Jr.,Ph.D., will provide an update.... To access the live audio broadcast or the subseq...
(Date:8/28/2008)...k by 67%, but patients and doctors say drug is har...hDay News) -- Only 40 percent of patients with atr...who did suffer a stroke were taking the anti-clott...hose taking warfarin, 75 percent weren,t getting t...nal 25 percent were taking medications that were l...
(Date:8/28/2008).... 28 /PRNewswire-FirstCall/ -- Versus,Technology, ...s of,$1,176,000 for its third fiscal quarter ended...ues of $1,283,000 for the same quarter of the prio..., 2008, were $4,026,000,compared to $3,554,000 fo...ase. Versus, quarterly revenues can vary significa...
Breaking Medicine News(10 mins):Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 2Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 3Health News:Versus Technology Announces Third Quarter Results 2Health News:Versus Technology Announces Third Quarter Results 3Health News:Versus Technology Announces Third Quarter Results 4Health News:Versus Technology Announces Third Quarter Results 5Health News:Versus Technology Announces Third Quarter Results 6
...ine developed by the American Academy of Neurology...iotics are highly effective for treating nervous s...ng evidence that prolonged treatment with antibiot...sist following standard therapy. The guideline is ...
...id arthritis, lupus, and other inflammatory rheuma...ath from heart disease. One explanation is a great...herosclerosis is linked to inflammation in healthy...on and the reason for accelerated atherosclerosis ...
...tact lens users beware of the AMO Complete Moistur...rnment investigation in the US has found that it c...ratitis, a rare yet severe eye infection. The di...s or blindness. The Centres for Disease Control an...
...ident, Dr Mukesh Haikerwal, welcomed Labors downpa...fe expectancy between Indigenous and non-Indigenou...der Kevin Rudd has committed to closing the gap if...ent, Dr Haikerwal said. Mr Rudd has committed $26...
Other Medicine News:Health News:Antibiotics Highly Effective for Treating Lyme Disease 2Health News:New Insights into Chronic Inflammation and Atherosclerosis 2Health News:Contact Lens Wearers Warned Against Using AMO Solution 2Health News:Contact Lens Wearers Warned Against Using AMO Solution 3
(Date:8/26/2008)...LEM, Ore., Aug. 26 /- The Oregon Tour...y Care Customer Service Training Program,(Q Care) ...n Q Care is a training program created to support ...ced employee education. By emphasizing,the importa... equip,employees with tools and resources to bette...
(Date:8/26/2008)...udy finds most patients can drive safely six weeks...g. 26 /PRNewswire-USNewswire/ -- Six weeks followi...so low that they are able to,get back behind the w...st,2008 issue of The Journal of Bone and Joint Sur...gency brake time response in patients who underwen...
(Date:8/26/2008)... Vaccine - Coupled with Innovative Manufacturing -...bal Pandemic Preparedness, ROCKVILLE, Md., Aug. 2... NVAX ) announced today favorable results from th...rial of its pandemic influenza virus-like,particle...not contain an,adjuvant, induced robust neutralizi...
(Date:8/25/2008)...LLESLEY HILLS, Mass., Aug. 25 /- Jose...assets of Spherics, Inc. ("Spherics") for,the bene...eutical,intellectual property will be sold at a se... an extended release formulation of Levodopa-Carbi...or Parkinson,s disease, with global,sales estimate...
Breaking Medicine Technology:Oregon Tourism Commission Unveils New Online Customer Service Training Program 2Braking After Bunion Surgery 2Braking After Bunion Surgery 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 4Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 5Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 6Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Milestone Scientific to Announce First Quarter 2008 Results on Thursday May 15 2008 19295 1Milestone Scientific to Announce First Quarter 2008 Results on Thursday May 15 2008 19295 2Milestone Scientific to Announce First Quarter 2008 Results on Thursday May 15 2008 19295 3Milestone Scientific to Announce First Quarter 2008 Results on Thursday May 15 2008 19295 4Milestone Scientific to Announce First Quarter 2008 Results on Thursday May 15 2008 19295 5Mylan Launches Paroxetine Hydrochloride Extended Release Tablets 19292 1Mylan Launches Paroxetine Hydrochloride Extended Release Tablets 19292 2Betting on Change The Venture Forum in 2008 5385 1Betting on Change The Venture Forum in 2008 5385 2Betting on Change The Venture Forum in 2008 5385 3Cynosure Appoints H Travis Lee as Vice President of Global Marketing 5382 1Cynosure Appoints H Travis Lee as Vice President of Global Marketing 5382 2Cynosure Appoints H Travis Lee as Vice President of Global Marketing 5382 3
...Were Maintained for at Least 24 Weeks, According,t...ON, May 15, 2007 /PRNewswire/ -- Researchers from ... Medicine have,announced the results from the firs...dy evaluating botulinum toxin type A (BTX-A,BOTOX...tivity (IDO),in patients with symptoms of overacti...
...INESS WIRE)--May 17, 2007 - Salix,Pharmaceuticals,...f,18 investigator-initiated trials related to the ...Disease Week(R) 2007, which will be,held May 19-24...argest and most prestigious meeting in the world f...e than 16,000 physicians,researchers and academic...
Other Medicine Technology:First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 2First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 3First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: